Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Iterum Therapeutics plc ITRM

Healthcare Biotechnology
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with... see more

Current News (NDAQ:ITRM)

Iterum Therapeutics Provides Business Update

GlobeNewswire December 23, 2025

Iterum Therapeutics Provides Business Update

GlobeNewswire December 17, 2025

Iterum Therapeutics Provides Business Update

GlobeNewswire December 5, 2025

Iterum Therapeutics Provides Business Update

GlobeNewswire November 24, 2025

Iterum Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire November 14, 2025

Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025

GlobeNewswire November 7, 2025

Iterum Therapeutics to Present Data at IDWeek 2025

GlobeNewswire October 14, 2025

Iterum Therapeutics Provides Business Update

GlobeNewswire September 19, 2025

Iterum Therapeutics launches ORLYNVAH(TM), the first and only oral penem antibiotic in the U.S.

GlobeNewswire August 20, 2025
View More News ››

Opinion & Analysis (NDAQ:ITRM)

Iterum Therapeutics Shares Double After Completing Enrollment in Phase 3 Antibiotic Trial

Streetwise Reports December 30, 2019
View More Opinion ››

Bullboard Posts (NDAQ:ITRM)

Partnership to revenue

So what's anyone's take the ITRM's partnership and commercialization to revenue?  Will they show market gains in Rx'...
Ltcguy2001 - June 26, 2025

RE:RE:RE:Iterum Therapeutics to Host Morning Conference Call on U.S.

Do they replace the board member?  If no, other MB's suggesting a buy out would be imminent.  They said $12-$17 range...
Ltcguy2001 - March 4, 2025

RE:RE:Iterum Therapeutics to Host Morning Conference Call on U.S.

Broke down and bought 1,500 shares to get me back to 5,000.  Hoping for relevant news in the next couple of months.
Ltcguy2001 - February 28, 2025

RE:Iterum Therapeutics to Host Morning Conference Call on U.S.

I was lucky to take a small 5,000 share position last Thursday @$1.20 and sold Friday at $2.18.  Took my $6k back off the table but...
Ltcguy2001 - October 28, 2024

Iterum Therapeutics plc: Resubmitted NDA for Oral Sulopenem

http://beyondspx.com/2024/08/02/iterum-therapeutics-plc-resubmitted-nda-for-oral-sulopenem-positions-company-for-potential-approval-in-q4...
MikeTester - August 3, 2024

ITRM ..... I'll take that profit ; )

Cheers !
Iseneschal - December 15, 2022
View more Bullboard ››

Algernon Health Inc.

Algernon Health Inc.

Algernon Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company ...
View More »

Podcasts